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Abstract 
Background: Tubulointerstitial nephritis antigen-like 1 protein (TINAGL1), is a matricellular protein, known to play 
role in cell adhesion and cell receptor interaction. Research related to TINAGL1 is limited to cell culture and animal 
models. Demonstration of TINAGL1 as a positive regulator of angiogenesis and its expression in the decidua of post-
implantation mouse uterus, prompted us to validate its expression in human placenta during impaired angiogenesis 
in pre-eclamptic condition.
Methods: Placental tissue from normotensive (n = 25) and pre-eclamptic (n = 25) pregnancies were used to study 
the differentially expressed proteins by two-dimensional gel electrophoresis and TINAGL1 protein was validated with 
Western blotting.
Results: A total of 55 protein spots were differentially expressed (fold change >1.5, p < 0.05), of which 27 were 
upregulated and 28 were downregulated in the pre-eclamptic placenta. TINAGL1 was found to be downregulated in 
pre-eclamptic compared to normotensive pregnant women.
Conclusion: This is the first study reporting TINAGL1 to be present in human placenta and differentially expressed 
in pre-eclamptic condition. The functional role of TINAGL1 in association to human pregnancy needs to be explored 
further.
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Proteomics
© The Author(s) 2017. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Background
Tubulointerstitial nephritis antigen-like 1 protein (TIN-
AGL1) also known as Lipocalin 7 (LCN7) or adreno-
cortical zonation factor-1 (AZ1) or tubulointerstitial 
nephritis antigen related protein (TIN-ag-RP) is a matri-
cellular protein. TINAGL1 is similar to tubulointerstitial 
nephritis antigen (TINAGL) in its protein domain com-
position, i.e. two EGF-like domains and a proteolytically 
inactive cathepsin B-like domain [1]. Unlike TINGAL, its 
expression is not limited to kidney, but found in a vari-
ety of organs, such as vascular smooth muscle [1], glo-
merular basement membrane [1], uterine capillaries [2], 
adrenocortical cells [3] and lung capillary endothelium 
[4]. As a matricellular protein, it interacts with other 
structural matrix proteins such as laminin, collagen, and 
fibronectin and plays a role of a ligand for cell integrins 
receptors such as α1β1, α2β1 and α5β1 [3]. Brown et  al. 
[5], using murine endothelial cell lines and zebrafish 
embryo demonstrated that TINGAL1 is a positive regu-
lator of angiogenesis that increases endothelial cell inva-
sion, angiogenic sprouting and sensitivity of TGF-β. The 
demonstration of marked expression of TINGAL1 in the 
decidua of postimplantation mouse uterus [2] and the 
blastocoelic surface of trophectoderm [6] has instigated 
the possible role of this protein in pregnancy.
Pre-eclampsia (PE) complicates 5–8% pregnancies 
and is a leading cause of maternal and perinatal mor-
bidity and mortality worldwide. PE is diagnosed by the 
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new onset of hypertension (>140/90  mmHg) accompa-
nied with new onset of proteinuria (>300 mg/24 h) after 
20  weeks of gestation, or in the absence of proteinuria, 
hypertension accompanied with new onset of any of the 
following symptoms viz. thrombocytopenia, renal insuf-
ficiency, impaired liver function, pulmonary edema and 
visual or cerebral symptoms [7]. Although the origin of 
PE remains enigmatic, the primary underlying cause is 
the abnormal placentation due to inefficient trophoblast 
invasion into the spiral artery. The reduced spiral artery 
remodeling leads to decreased blood flow to the placenta, 
making it more hypoxic. As a consequence of oxidative 
stress, inflammation and apoptosis varying pathophysi-
ological problems such as immunological, generalized 
endothelial dysfunctions and placental ischemia arise 
in these women [8, 9]. The role of the placenta in pre-
eclampsia is undeniable, thus needs to be explored 
further. We investigated the placental proteome of pre-
eclamptic women using proteomic techniques and found 
expression of TINAGL1 in the placenta.
Methods
Sample collection
Patients recruited for the study were classified as PE if 
they showed systolic and diastolic blood pressures >140 
and 90  mmHg, respectively, with the presence of pro-
teinuria (>1+ or 300  mg/24  h) on a dipstick test and 
was confirmed by repeated recording of the blood pres-
sure with an interval of 6 h. Women with an indication 
of chronic hypertension, type 1 or 2 diabetes mellitus, 
renal or liver diseases and seizure disorder were excluded 
from the study. The sample set used in this study is same 
as our earlier study [10]. All samples were collected from 
Department of Obstetrics and Gynecology, Bharati Hos-
pital, Pune, Maharashtra, India with informed consent 
from the patient and were approved by the Bharati Vid-
yapeeth Medical College Institutional Ethical Committee. 
Small sections of placental tissues from normotensive 
and pre-eclamptic pregnancies were collected immedi-
ately after delivery and rinsed with phosphate buffered 
saline to wash off the blood, snap frozen in liquid nitro-
gen and stored at −80 °C until further use.
Protein extraction, separation, and identification
Frozen placental tissue was pulverized, and dissolved 
in lysis buffer (100 mg/0.5 ml) (7 M urea, 2 M thiourea, 
4% 3-[(3-cholamidopropyl) dimethylammonio]-1-pro-
panesulfonate, 2% Dithiothreitol). The homogenate was 
centrifuged and the supernatant used as a source of pla-
cental proteins. Two technical replicates of three pools 
of normotensive (n  =  18) were compared with three 
pools of PE (n = 18) protein samples using two-dimen-
sional electrophoresis (2DE). For the first dimension, 
immobilized pH gradient (IPG) strips 4–7 and 12% 
Tris–Glycine SDS-PAGE gels for the second dimension 
electrophoresis were used. The stained gels images were 
scanned on GS-800 Densitometer and analyzed for spot 
intensity data by PDQuest software (Bio-Rad Labora-
tories, Hercules, CA, USA). Protein spots excised from 
2DE were de-stained, followed by reduction and alkyla-
tion. Digested peptides were analyzed in LC-MSE using 
a NanoAcquity ultra-performance liquid chromatogra-
phy (UPLC) system coupled to an SYNAPT high defini-
tion mass spectrometer (Waters, Milford, MA, USA). 
Nano C18 reversed phase column (1.7  μm particle size, 
i.d. 75 μm and length 250 mm) (Waters) and binary sol-
vent system (99.9% water and 0.1% formic acid (mobile 
phase A) and 99.9% acetonitrile and 0.1% formic acid 
(mobile phase B)) was used for peptide separation. Data 
were processed and searched using ProteinLynx Global 
Server 2.4 (PLGS) software (Waters). UniProtKB H. sapi-
ens proteome (UP000005640), including only reviewed 
sequences (47,869) from UniprotKB/SwissProt (updated 
version of H. sapiens proteome, 2008) was used to search 
against the MS data. A fixed modification included car-
bamidomethyl C and variable modifications such as oxi-
dation M, deamidation N, and deamidation Q. Automatic 
setting of PLGS was used for mass accuracy of precursor 
and fragment ions. Identification was done with mini-
mum two peptides and FDR of 1%. For each protein iden-
tified, a number of unique peptides for a given protein 
was calculated using PepServe bioinformatics tool. The 
dataset (PASS00711) was uploaded to publicly accessible 
PeptideAtlas database (www.peptideatlas.org, Institute 
for Systems Biology, Seattle, WA).
Western blot analysis
For validation of TINAGL1, placental proteins from nor-
motensive (n = 25) and pre-eclamptic (n = 25) were sep-
arated on SDS-PAGE and blotted onto one single PVDF 
membrane (Millipore Corporation, Billerica, MA, USA). 
Multi-strip Western blotting protocol was performed all 
50 individual protein samples as mentioned in Aksami-
tiene et al. [11]. All antibodies were purchased from Santa 
Cruz Biotechnology (Santa Cruz, CA, USA) and used as 
follows: primary antibody for tubulointerstitial nephri-
tis antigen-like 1 protein (1:2000), beta-actin (1:5000) as 
housekeeping, secondary anti-goat conjugated to biotin 
(1:10,000) and streptavidin conjugated HRP (1:20,000). 
Detection was performed by chemiluminescent ECL rea-
gent (GE Healthcare, Little Chalfont, BUX, UK) and sig-
nals were detected with CCD imaging system (Syngene, 
Cambridge, UK) camera. Analysis of total signal intensity 
of Western blot bands was performed with Image Studio 
Lite version 4.0 (Li-Cor Biosciences, Lincoln, NE, USA) 
using local background subtractions.
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Statistical analysis
Analysis of statistical significance of differential 
expressed protein 2D protein spots and Western blot 
protein bands were carried out using one-tailed Student’s 
t test. Analyzes were performed using SPSS/Pc package 
software version 18.0 (Chicago, IL, USA) and results were 
considered statistically significant if p ≤ 0.05.
Result
In the typical 2DE gels over 228 protein spots were 
detected in placental protein extracts, of which 55 pro-
tein spots were differentially expressed. We identified 
27-upregulated and 28-downregulated protein spots in 
PE compared to the normotensive placenta. It was nota-
ble that 9-protein spots were upregulated more than 
twofold in PE, while 7-protein spots were upregulated 
more than twofold in normotensive placental tissue with 
high confidence (p  ≤  0.05). The identified differentially 
expressed placental protein spots in pre-eclamptic and 
normotensive proteins with their molecular weight and 
isoelectric point, fold change with p value are listed in 
Additional file 1: Figure S1. Differentially expressed pro-
teins showed increased expression of molecular chap-
erones such as 60  kDa HSP mitochondrial, heat shock 
cognate 71  kDa protein, HSP70  kDa, while of HSP90, 
endoplasmin and hypoxia up-regulated protein-1 showed 
decreased expression in PE. The endoplasmic reticulum 
stress related proteins such as endoplasmin, hypoxia up-
regulated protein-1, transitional endoplasmic reticulum 
ATPase were downregulated, and protein disulphide 
isomerase A6 and thioredoxin domain containing protein 
5 were upregulated in PE group. Alpha-actinin family of 
proteins, alpha-actinin-1, -2, -3 and -4 were observed to 
be downregulated in pre-eclamptic group. These proteins 
are actin-binding proteins and have various functions in 
different cell types such as platelet activation and degran-
ulation, blood coagulation, hypoxia and apoptosis.
This is the first study reporting the expression of TIN-
AGL1 in pre-eclamptic condition. The conventional 
protein separation on two-dimensional SDS-PAGE, iden-
tified TINAGL1 protein spot with 6.5 isoelectric point 
and molecular weight of approximately 52  kDa. It was 
down-regulated in the placenta of pre-eclamptic women 
with a fold change of 1.6 (p = 0.004) (Fig. 1). Mass spec-
trometric analysis identified 68 and 54 peptides with a 
sequence coverage of 61 and 42% in normotensive and 
pre-eclamptic patients, respectively (Additional file  2: 
Table S1). Validation of TINGAL1 was performed by 
western blot of individual normotensive (n  =  25) and 
pre-eclamptic (n = 25) patient’s placenta. Similar to 2DE 
results, we observed 1.5 (p = 0.022) fold decrease of TIN-
GAL1 in the placenta of pre-eclamptic women in West-
ern blot analysis (Fig. 2; Additional file 3: Table S2).
Discussion
TINAGL1 is reported to be present in other tissue as well 
as in placenta [12]. Human protein atlas shows its maxi-
mum RNA expression in placenta. TINAGL1’s molecu-
lar functions are not well explored in human pregnancy 
or pre-eclampsia. Most of its biological role is studied 
in the mouse. Human TINAGL1 shows 90% amino acid 
sequence identity with mouse protein. TINAGL1 acts as 
a ligand for integrins α1β1, α2β1 and α5β1, suggesting its 
role in cell adhesion [2, 3]. Expressions of these integrins 
are important for trophoblast invasion [13]. Recently, 
Tinagl1−/− mice were shown to have impaired fertility 
during pregnancy [14].
Angiogenesis is one of the major events during preg-
nancy. Imbalance in angiogenic factors is one of the 
major events in the pathogenesis of pre-eclampsia [15]. 
Fig. 1 Magnified images of differentially expressed TINAGL1 spots. The bar chart represents mean ± SE of the optical density of the spot for the 
three sets of normotensive (C) and pre-eclamptic (PE). **p < 0.01
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The discovery of TINAGL1 as a pro-angiogenic factor 
in in  vitro and in  vivo models of angiogenesis [5], has 
set off its possibility to play a role in angiogenesis during 
pregnancy. Low level of TINAGL1 in the placenta of pre-
eclamptic women might be one of the factors in impaired 
angiogenesis and cell adhesion which needs to me 
explored further. Studying its molecular mechanism in 
earlier stages of gestation in the human will be challenging 
and one needs to rely on animal models of pre-eclampsia.
Conclusion
In conclusion, during our preliminary investigation on 
the placental proteome of pre-eclamptic and normoten-
sive women by two-dimensional gel electrophoresis, we 
identified tubulointerstitial nephritis antigen-like 1 pro-
tein as one of the differentially expressed proteins that 
are hitherto not studied in pre-eclampsia. Hence, we 
validated the expression of this protein in placental tissue 
(n = 50) of pre-eclamptic and normotensive subjects.
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